LuP, YuB, XuJ. Cucurbitacin B regulates immature myeloid cell differentiation and enhances antitumor immunity in patients with lung cancer. Cancer Biother Radiopharm, 2012; 27:495.
2.
ZhouX, YangJ, WangYet al.Cucurbitacin B inhibits 12-O-tetradecanoylphorbol 13-acetate-induced invasion and migration of human hepatoma cells through inactivating mitogen-activated protein kinase and PI3K/Akt signal transduction pathways. Hepatol Res, 2012; 42:401.
3.
ZhangM, SunC, ShanXet al.Inhibition of pancreatic cancer cell growth by cucurbitacin B through modulation of signal transducer and activator of transcription 3 signaling. Pancreas, 2010; 39:923.
4.
IwanskiGB, LeeDH, En-GalSet al.Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer. Br J Pharmacol, 2010; 160:998.
5.
LiuT, PengH, ZhangM, DengY, WuZ. Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin. Eur J Pharmacol, 2010; 641:15.
6.
ZhangY, OuyangD, XuLet al.Cucurbitacin B induces rapid depletion of the G-actin pool through reactive oxygen species-dependent actin aggregation in melanoma cells. Acta Biochim Biophys Sin (Shanghai), 2011; 43:556.
7.
OuyangD, ZhangY, XuLet al.Histone deacetylase inhibitor valproic acid sensitizes B16F10 melanoma cells to cucurbitacin B treatment. Acta Biochim Biophys Sin (Shanghai), 2011; 43:487.
8.
ChenW, LeiterA, YinDet al.Cucurbitacin B inhibits growth, arrests the cell cycle, and potentiates antiproliferative efficacy of cisplatin in cutaneous squamous cell carcinoma cell lines. Int J Oncol, 2010; 37:737.
9.
IshdorjG, JohnstonJB, GibsonSB. Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B leukemic cells. BMC Cancer, 2011; 11:268.
10.
LeeDH, ThoennissenNH, GoffCet al.Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma. Cancer Lett, 2011; 306:161.
